Kronos Bio (KRON) Insider Trading & Ownership $0.96 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kronos Bio (NASDAQ:KRON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.79 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$43,196.58 Get KRON Insider Trade Alerts Want to know when executives and insiders are buying or selling Kronos Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KRON Insider Buying and Selling by Quarter Ad Jack Carter Trading"X-Ray Vision" could find thousands of hidden market opportunitiesLet me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.Just tap here to join the presentation. Kronos Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/27/2024Norbert W BischofbergerCEOBuy410,848$1.17$480,692.16 6/12/2024Norbert W BischofbergerCEOBuy881,913$1.24$1,093,572.12 6/10/2024Norbert W BischofbergerCEOBuy1,378,901$0.88$1,213,432.88 2/21/2024Elizabeth A OlekSVPSell7,368$1.05$7,736.40 1/4/2024Barbara KosaczCOOSell10,676$1.18$12,597.68 1/4/2024Christopher DinsmoreInsiderSell7,366$1.18$8,691.88 1/4/2024Jorge DimartinoVPSell12,009$1.18$14,170.62 (Data available from 1/1/2013 forward) KRON Insider Trading Activity - Frequently Asked Questions Who is on Kronos Bio's Insider Roster? The list of insiders at Kronos Bio includes Barbara Kosacz, Christopher Dinsmore, Elizabeth A Olek, Jorge Dimartino, Norbert W Bischofberger, and Yasir B Al-Wakeel. Learn more on insiders at KRON. What percentage of Kronos Bio stock is owned by insiders? 24.40% of Kronos Bio stock is owned by insiders. Learn more on KRON's insider holdings. Which Kronos Bio insiders have been buying company stock? The following insider purchased KRON shares in the last 24 months: Norbert W Bischofberger ($3,990,017.36). How much insider buying is happening at Kronos Bio? Insiders have purchased a total of 4,140,285 KRON shares in the last 24 months for a total of $3,990,017.36 bought. Which Kronos Bio insiders have been selling company stock? The following insiders have sold KRON shares in the last 24 months: Barbara Kosacz ($12,597.68), Christopher Dinsmore ($44,289.32), Elizabeth A Olek ($7,736.40), Jorge Dimartino ($73,345.44), and Yasir B Al-Wakeel ($32,534.99). How much insider selling is happening at Kronos Bio? Insiders have sold a total of 117,357 Kronos Bio shares in the last 24 months for a total of $170,503.83 sold. Kronos Bio Key ExecutivesDr. Norbert W. Bischofberger Ph.D. (Age 68)President, CEO & Director Compensation: $912.2k1 recent tradesMr. Joshua A. Kazam (Age 47)Co-Founder & Director Compensation: $40kMr. David M. Tanen J.D. (Age 53)Secretary & Director Compensation: $40kMs. Sandra A. Gardiner (Age 58)Interim CFO & Principal Accounting Officer Dr. Margaux Bennett Ph.D.Vice President of Corporate Development & Investor RelationsMs. Allison Frisbee J.D. (Age 41)Senior Vice President of Corporate Operations & Legal Dr. Charles Lin Ph.D. (Age 39)Senior Vice President of Research & Development Dr. Elizabeth A. Olek D.O. (Age 59)M.P.H., Senior Vice President of Clinical Development Mr. Wes Trotter Ph.D.Senior Vice President of Drug Discovery & Pharmaceutical DevelopmentMs. Rocio Martin HoyosSenior Vice President of Corporate Strategy & Portfolio Management More Insider Trading Tools from MarketBeat Related Companies ATAI Insider Trading TNYA Insider Trading ACRV Insider Trading ACRS Insider Trading BMEA Insider Trading INBX Insider Trading LFVN Insider Trading CRDF Insider Trading CMPX Insider Trading MGNX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:KRON) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kronos Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.